Related Experiment Video

Updated: Aug 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[Risk factors of atherosclerosis in end-stage renal disease patients]

Shuichi Jono1

  • 1Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Clinical Calcium
|December 4, 2004
PubMed

Insights

Patients with end-stage renal disease (ESRD) face high risks of atherosclerotic disease, often marked by vascular calcification. Key risk factors include traditional coronary issues and hyperphosphatemia, with bone proteins potentially influencing atherosclerosis progression.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Context:

  • End-stage renal disease (ESRD) patients exhibit significantly increased risks for atherosclerotic disease.
  • Vascular calcification is a prevalent characteristic of advanced atherosclerosis in ESRD populations.
  • Traditional coronary risk factors like hypertension, diabetes, and hyperlipidemia are common in ESRD patients.

Purpose:

  • To explore the multifaceted risk factors contributing to atherosclerosis in ESRD patients.
  • To investigate the potential role of bone-associated proteins in the progression of vascular calcification and atherosclerosis within this patient group.

Summary:

  • ESRD patients have elevated risks of atherosclerosis and vascular calcification.
  • Risk factors include hypertension, diabetes, hyperlipidemia, and hyperphosphatemia.
  • Bone-associated proteins such as osteopontin, matrix Gla protein, and osteoprotegerin are implicated in atherosclerosis progression.

Impact:

  • Highlights the complex interplay of traditional and unique risk factors in ESRD-related atherosclerosis.
  • Suggests novel therapeutic targets by implicating bone-associated proteins in vascular disease.
  • Emphasizes the need for comprehensive cardiovascular risk management in ESRD patients.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...